Wilhelmina Ziekenhuis Assen

The research here focuses on neoplasms, with studies centered on breast cancer and prostate cancer. These trials are designed to assess whether new or adjusted hormone-based treatments can improve outcomes for people at higher risk of recurrence or reduce the burden of long-term therapy.

• Evaluating a new endocrine therapy approach for early breast cancer to help lower the risk of the disease returning.
• Studying treatment duration in low-volume metastatic castration-sensitive prostate cancer to see if shorter use of androgen receptor signaling inhibitors can remain effective.

Overall, the site is contributing to research that aims to refine cancer treatment, improve quality of care, and balance effectiveness with fewer side effects and lower treatment burden.